Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gourlay

Showing results (731-740 of 734) with videos related to

Pageof 74
Sort By:
You have reached the last page of results.This site can display upto 734 results.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Microbial Cell (Graz, Austria)|January 23, 2018
Guidelines and recommendations on yeast cell death nomenclatureDidac Carmona-Gutierrez, Maria Anna Bauer, Andreas Zimmermann, et al.
Pageof 74

Showing results (731-740 of 734) with videos related to

Sort By:
Pageof 74
You have reached the last page of results.This site can display upto 734 results.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Microbial Cell (Graz, Austria)|January 23, 2018
Guidelines and recommendations on yeast cell death nomenclatureDidac Carmona-Gutierrez, Maria Anna Bauer, Andreas Zimmermann, et al.
Pageof 74